{{Rsnum
|rsid=1559759
|Chromosome=11
|position=35101504
|Orientation=minus
|GMAF=0.186
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 69.9 | 26.5 | 3.5
| HCB | 42.3 | 41.6 | 16.1
| JPT | 53.1 | 42.5 | 4.4
| YRI | 83.0 | 15.6 | 1.4
| ASW | 71.9 | 26.3 | 1.8
| CHB | 42.3 | 41.6 | 16.1
| CHD | 42.2 | 39.4 | 18.3
| GIH | 42.6 | 51.5 | 5.9
| LWK | 71.8 | 26.4 | 1.8
| MEX | 84.5 | 15.5 | 0.0
| MKK | 66.7 | 30.1 | 3.2
| TSI | 61.8 | 32.4 | 5.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=A
  |Pval=9E-6
  |OR=25.59
  |ORtxt=[14.3-36.88] mg/dL increase
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}